P3 Health Partners (NASDAQ:PIII) Trading Up 5.8% – What’s Next?

Shares of P3 Health Partners Inc. (NASDAQ:PIII) were up 5.8% during mid-day trading on Wednesday . The company traded as high as $9.49 and last traded at $9.41. 17,810 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 70,183 shares. The stock had previously closed at $8.89.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. TD Cowen reaffirmed a “hold” rating and issued a $14.00 price target (up from $3.00) on shares of P3 Health Partners in a report on Friday, May 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of P3 Health Partners in a research report on Tuesday, August 25th. Wall Street Zen upgraded P3 Health Partners to a “hold” rating in a research report on Saturday, July 4th. UBS Group set a $14.00 price objective on P3 Health Partners in a report on Friday, May 15th. Finally, Lake Street Capital restated a “buy” rating and issued a $23.00 price objective on shares of P3 Health Partners in a report on Tuesday, August 11th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $17.00.

P3 Health Partners Stock Performance

The firm has a market cap of $68.33 million, a PE ratio of -0.29 and a beta of 1.63. The company’s 50-day simple moving average is $10.46 and its two-hundred day simple moving average is $7.37.

P3 Health Partners (NASDAQ:PIII) last posted its earnings results on Monday, August 10th. The company reported ($0.63) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.89) by $1.26. The business had revenue of $386.38 million during the quarter, compared to the consensus estimate of $377.80 million.

Insider Buying and Selling

In related news, major shareholder Hudson Vegas Investment Spv, L sold 50,000 shares of P3 Health Partners stock in a transaction on Monday, August 10th. The shares were sold at an average price of $16.48, for a total value of $824,000.00. Following the sale, the insider owned 48,959 shares in the company, valued at $806,844.32. The trade was a 50.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 10.86% of the stock is owned by insiders.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in P3 Health Partners stock. Lido Advisors LLC bought a new position in P3 Health Partners Inc. (NASDAQ:PIII) in the 1st quarter, according to its most recent disclosure with the SEC. The firm bought 10,748 shares of the company’s stock, valued at approximately $33,000. Lido Advisors LLC owned 0.15% of P3 Health Partners at the end of the most recent quarter. Institutional investors and hedge funds own 7.75% of the company’s stock.

About P3 Health Partners

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.